Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle?
暂无分享,去创建一个
R. Paus | J. Schuetz | I. Haslam | A. Pitre
[1] J. Lademann,et al. Drug delivery to hair follicles , 2013, Expert opinion on drug delivery.
[2] R. Paus,et al. Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. , 2013, The Journal of investigative dermatology.
[3] Ralf Paus,et al. Pathobiology of chemotherapy-induced hair loss. , 2013, The Lancet. Oncology.
[4] Zhe-Sheng Chen,et al. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202. , 2012, Molecular pharmaceutics.
[5] Tetsuro Kobayashi,et al. Isolation and characterization of stem cell-enriched human and canine hair follicle keratinocytes. , 2012, Methods in molecular biology.
[6] D. Ross,et al. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. , 2012, Biochemical pharmacology.
[7] Lonneke V. van de Poll-Franse,et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry , 2012, Acta oncologica.
[8] W. Sterry,et al. Nanoparticles in dermatology , 2011, Archives of Dermatological Research.
[9] P. Couttet,et al. Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice , 2011, PloS one.
[10] A. Tosti,et al. Permanent chemotherapy-induced alopecia: a review. , 2011, Journal of the American Academy of Dermatology.
[11] M. Cabot,et al. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity. , 2010, International journal of oncology.
[12] C. Gilissen,et al. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells , 2010, BMC pharmacology.
[13] X. Wu,et al. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. , 2010, Advanced drug delivery reviews.
[14] P. Karnik,et al. Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. , 2009, Archives of dermatology.
[15] Kevin D Cooper,et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. , 2009, The Journal of investigative dermatology.
[16] Rita Padányi,et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. , 2008, Biochimica et biophysica acta.
[17] N. Simmons,et al. Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84). , 2008, Biochemical pharmacology.
[18] R. Paus,et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche , 2008, Experimental dermatology.
[19] A. Riva,et al. Topical anti‐inflammatory activity of extracts and compounds from Hypericum perforatum L. , 2007, The Journal of pharmacy and pharmacology.
[20] M. Ohyama. Hair follicle bulge: a fascinating reservoir of epithelial stem cells. , 2007, Journal of dermatological science.
[21] E. Barta,et al. Peroxisome Proliferator-activated Receptor γ-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells* , 2006, Journal of Biological Chemistry.
[22] Alfonso Lampen,et al. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. , 2005, Carcinogenesis.
[23] M. Fujimoto,et al. Characterization and Localization of Side Population Cells in Mouse Skin , 2005, Stem cells.
[24] R. Johnstone,et al. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation , 2002, Cell Death and Differentiation.
[25] L. Rogers,et al. Psychological sequelae and alopecia among women with cancer. , 2001, Cancer practice.
[26] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[27] I. Roninson,et al. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.
[28] M. Messadi,et al. Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia. , 1975, American journal of ophthalmology.
[29] R. Callaghan,et al. Review/Drug Metabolism and Transport: P-glycoprotein: So Many Ways to Turn It On , 2008 .
[30] F. Sharom. ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.
[31] T. Seyama,et al. Radiation sensitivity of human hair follicles in SCID-hu mice. , 1998, Radiation research.